Cite
MLA Citation
Yoshihiko Sakata et al.. “The effects of switching EGFR‐TKI treatments for non‐small cell lung cancer because of adverse events.” Asia-Pacific journal of clinical oncology, vol. 16, no. 2, 2020, pp. e113–e117. http://access.bl.uk/ark:/81055/vdc_100102739630.0x00000b